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We have applied convolution methods to account for some of the effects of respiratory induced
motion in clinical treatment planning of the lung. The 3-D displacement of the GTV center-of-mass
~COM! as determined from breath-hold exhale and inhale CT scans was used to approximate the
breathing induced motion. The time-course of the GTV-COM was estimated using a probability
distribution function ~PDF! previously derived from diaphragmatic motion @Med. Phys. 26, 715–
720 ~1990!# but also used by others for treatment planning in the lung @Int. J. Radiat. Oncol., Biol.,
Phys. 53, 822–834 ~2002!; Med. Phys. 30, 1086–1095 ~2003!#. We have implemented fluence and
dose convolution methods within a Monte Carlo based dose calculation system with the intent of
comparing these approaches for planning in the lung. All treatment plans in this study have been
calculated with Monte Carlo using the breath-hold exhale CT data sets. An analysis of treatment
plans for 3 patients showed substantial differences ~hot and cold spots consistently greater than
615%) between the motion convolved and static treatment plans. As fluence convolution accounts
for the spatial variance of the dose distribution in the presence of tissue inhomogeneities, the doses
were approximately 5% greater than those calculated with dose convolution in the vicinity of the
lung. DVH differences between the static, fluence and dose convolved distributions for the CTV
were relatively small, however, larger differences were observed for the PTV. An investigation of
the effect of the breathing PDF asymmetry on the motion convolved dose distributions showed that
reducing the asymmetry resulted in increased hot and cold spots in the motion convolved distribu-
tions relative to the static cases. In particular, changing from an asymmetric breathing function to
one that is symmetric results in an increase in the hot/cold spots of 615% relative to the static plan.
This increase is not unexpected considering that the target spends relatively more time at inhale as
the asymmetry decreases ~note that the treatment plans were generated using the exhale CT
scans!. © 2004 American Association of Physicists in Medicine. @DOI: 10.1118/1.1669083#
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convolutionI. INTRODUCTION
Conformal radiotherapy treatment planning is typically
based on a single CT scan, which represents one instance of
the patient anatomy. However, in order to more accurately
estimate the dose to the tumor, it is important in such sites as
the lung and liver, that the respiratory-induced motion be
accounted for within the dose calculations. Differences that
result between the planned dose distributions in the static and
motion-compensated cases can be clinically significant ~par-
ticularly in the context of dose escalation!, as pointed out in
a recent study by Rosu et al.,4 involving treatment planning
of tumors in the liver. Several investigators have proposed
methods to account for organ motion in treatment
planning.1–7,11 One traditional approach has been to convolve
the static dose distributions with functions that approximate
the breathing.1,7 In particular, the application of this ap-
proach for treatment planning in the liver by Lujan et al.1 has
shown that applying a single convolution to the static dose
distribution is sufficient to predict the dose distribution for
the given fractionated treatment; intra-fraction effects were925 Med. Phys. 31 4, April 2004 0094-2405Õ2004Õ31found to average out over the course of many fractions. Po-
tential limitations1,8,9 of the dose convolution approach in-
clude the following assumptions: ~a! the dose is spatially
invariant for small changes in the geometry ~i.e., the convo-
lution of the dose is conducted in an assumed homogeneous
medium!, ~b! the motion is based on a rigid body approxi-
mation, and ~c! the method applies over an ‘‘infinite’’ num-
ber of fractions.
More recently, the use of Monte Carlo based dose calcu-
lation algorithms have facilitated a new approach to account
for random setup errors10 and breathing-induced motion.11
This approach termed ‘‘fluence convolution’’ is performed by
convolving the particle fluence with the appropriate motion-
related functions. Fluence convolution is based on the reci-
procity principle of motion between the incident fluence and
the patient—convolving the fluence with the patient anatomy
held fixed is theoretically equivalent to shifting patient
anatomy with the fluence being stationary.10 The benefit of
fluence convolution over dose convolution is that it is based
on a direct simulation approach, that is, the dose is recalcu-9254Õ925Õ8Õ$22.00 © 2004 Am. Assoc. Phys. Med.
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lated dose distribution is therefore not spatially invariant as
in the case of dose convolution. However, as with dose con-
volution, fluence convolution is also limited by the rigid
body approximation and by the fact that dose fraction effects
are ignored.
The intent of this study was to apply convolution methods
~both fluence and dose convolution! to account for some of
the effects of respiratory-induced motion of the gross tumor
volume ~GTV! in treatment planning for lesions located
within the lung. Motion of the GTV has been estimated by
evaluating the excursion of the center-of-mass ~COM! be-
tween normal breath-hold exhale and inhale CT scans. We
compare calculations using the convolution implementations
with those from the static ~no motion case! for the CTV and
PTV. In all cases, treatment plans have been generated using
a Monte Carlo based dose calculation algorithm.
II. METHODS AND MATERIALS
A. Image acquisition and target center-of-mass
motion
As part of a new CT imaging study protocol ~at our insti-
tution! for patients with lung cancer, CT data are acquired in
the normal breath-hold inhale and exhale positions, as well
as at an arbitrary free-breathing state. In this study, the
breath-hold inhale and exhale CT scans were used to esti-
mate the center-of-mass ~COM! motion of the gross tumor
volume ~GTV!. The GTV was delineated by the physician on
the inhale and exhale CT data sets. The treatment planning
volumes: GTV, clinical target volume ~CTV!, and planning
target volume ~PTV! are those recommended by the ICRU
Report No. 50.12 During standard ~static! treatment planning,
the GTV is outlined on the breath-hold exhale CT scan; the
CTV is formed by a uniform, 0.5 cm expansion of the GTV
and the PTV includes a further 1.0 cm uniform expansion for
setup uncertainties and breathing-induced motion of the tu-
mor.
The general methodology for assessing target motion was
to calculate the displacement of the GTV-COM between in-
hale and exhale extents of breathing. This was accomplished
by calculating the COM coordinates on the inhale and exhale
CT scans using the equation
xcom5
( ix imi
( imi
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( imi
, zcom5
( iz imi
( imi
, ~1!
where xi , yi , zi represent the coordinates, and mi the mass
of voxel i . Voxels for the COM calculation constitute the
3-D generated GTV volume within the treatment planning
system ~UMPlan!. The displacement vector of the GTV-
COM (Rcom) between inhale and exhale is then given by the
equation
Rcom~x ,y ,z !5~xI2xE! iˆ1~yI2yE! jˆ1~zI2zE!kˆ , ~2!
where the subscripts I represent the COM coordinates in the
inhale position and the subscripts E represent those in the
exhale position.Medical Physics, Vol. 31, No. 4, April 2004B. Monte Carlo virtual source model and the
convolution implementations
1. Monte Carlo virtual source model
A virtual source model13,14 has been developed for Monte
Carlo dose calculations using the Dose Planning Method
~DPM! Monte Carlo code system15—this system has been
integrated into our in-house treatment planning system, UM-
Plan ~University of Michigan, Ann Arbor, MI!. The source
model was reconstructed from phase space calculations of
the treatment head components of a Varian 21EX linear ac-
celerator ~Varian Associates, Palo Alto, CA! generated with
the BEAMnrc Monte Carlo code ~CNRC, Ottawa, CN!. The
source particle’s position and energy are sampled from the
respective fluence and bremsstrahlung distributions, and the
direction is calculated assuming that the particle emerged
from a point. Arbitrary field shapes are simulated by multi-
plying the uncollimated fluence map by a matrix describing
the MLC configuration. In order to account for the finite
width of the target and leaf edge penumbral effects, the
shaped-beam fluence map is convolved with a Gaussian ker-
nel as described previously.13
2. Fluence convolution and motion of the COM
The general fluence convolution method involves con-
volving the static beam fluence with a function that describes
the respiratory-induced motion. In this paper we use the fol-
lowing notation: Fstatic represents the MLC-shaped field
static fluence distribution, Fmotion the function describing the
breathing motion, and Fmotion the convolved fluence map
which incorporates the motion. For a point, r , that undergoes
the motion, we have
Fmotion~r !5Fmotion^ Fstatic
5E
r8
Fmotion~r2r8!Fstatic~r8!dr8. ~3!
Fmotion , is the probability distribution function ~PDF! de-
rived from the position–time function for tumor motion, and
may be estimated by observing the breathing-induced motion
under fluoroscopy as described previously by other
investigators.2,3,16,17 To estimate the GTV-COM position as a
function of time we use a function originally proposed by
Lujan et al.1 to account for breathing-induced ~superior–
inferior! motion in treatment planning of lesions in the liver.
This function is given by
z~ t!5z02a cos
2n~pt/t2f!, ~4!
where z0 is the position at exhale, a the amplitude of the
motion, t the period of the breathing cycle, n a parameter
that determines the degree of asymmetry of the model ~i.e.,
how much the respiratory cycle is biased toward exhale!, and
f the starting phase of the breathing cycle.1 In this study we
assume that the GTV-COM moves according to the function
in Eq. ~4! along a trajectory Rcom(x ,y ,z). Lujan et al.1 show
further that Eq. ~4! can be recast to yield a probability that a
point lies between z and z1dz , which is equal to the fraction
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and t1dt . The resulting PDF ~labeled Fmotion), upon replac-
ing z with r is as follows:
Fmotion~r !5H napS R02ra D (2n21)/2n
3F12S R02r
a
D 1/nG1/2J 21,
for R02a,r,R0 , ~5!
where R0 represents the position of the GTV-COM at exhale,
and r the arbitrary position along the trajectory Rcom(x ,y ,z).
The assumption here is that the 3-D vector Rcom(x ,y ,z) fol-
lows the same time course as the 1-D displacement, z. All
other parameters are the same as those defined in Eq. ~4!
above.
In this study, we have not monitored the tumor location as
a function of time but have assumed that the tumor has a
rectilinear trajectory following the time course described in
Eq. ~4!. Although Eq. ~4! may have limited applicability to
individual patients, it has been found to provide a reasonable
fit to population-based lung tumor motion.2,3 In particular,
Seppenwoolde et al.,2 who fluoroscopically imaged im-
planted markers for 20 lung cancer patients, found that Eq.
~4! provided a reasonable fit of the breathing-induced tumor
motion in these patients. Seppenwoolde et al.2 classified tu-
mors according to those in the upper, middle and lower lobes
of the lung and found that the degree of asymmetry of the
breathing function ~determined by the parameter n in Eqs.
~4!, ~5!! generally varied between n51 and 3. Recently En-
gelsman et al.3 conducted a theoretical treatment planning
study in which they assume that the lung tumor motion is
described by Eq. ~4! with a value of n53. We include an
analysis of the influence of the asymmetry of the breathing
function on the dose distributions by conducting fluence con-
volved calculations with values of n varying from 1 to 3 ~see
Figs. 1–3!.
In the Monte Carlo implementation, Fmotion is divided into
m probability bins, from the position at exhale (R0) to the
position at inhale (R02a). The first m21 bins are equally
FIG. 1. Probability as a function of amplitude of the GTV center-of-mass
~COM! motion as represented in Eq. ~5!. Plots are shown for functions with
varying degrees of asymmetry, n51 – 3. The amplitude of motion is 1.5 cm.Medical Physics, Vol. 31, No. 4, April 2004spaced—we use 3 mm bins to match the dose scoring voxel
size—with the last bin being of arbitrary width in order to
sample the correct Rcom amplitude. For example, if the am-
plitude of Rcom is 1.4 cm the first 4 bins would have width 3
mm, and the last bin would have width 2 mm. The position
(x , y at a fixed z location! and energy for each particle
starting from the virtual source is determined by first sam-
pling Fstatic . The source particle’s incident direction is deter-
mined from the position coordinates assuming that the par-
ticle originated from a point,13 i.e., u5x/r8, v5y /r8, w
5z/r8, where r85(x21y21z2)0.5. To account for the GTV-
COM motion in the Rcom direction, Fmotion is sampled to
determine the positional translation, dRcom . The translations
dx , dy , and dz are determined according to the relations
dx5
dRcom
uRcomu
~xI2xE!, dy5
dRcom
uRcomu
~yI2yE!,
~6!
dz5
dRcom
uRcomu
~zI2zE!,
where uRcomu5(xI2xE)21(yI2yE)21(zI2zE)20.5. The
following relation may then be used to describe the coordi-
nate transformation from the static fluence distribution
Fstatic , in the unprimed coordinates, to the motion convolved
fluence, Fmotion , in the primed coordinates:
x85x2dx , y85y2dy , z85z2dz . ~7!
FIG. 2. Percentage dose difference maps ~patient A! in the coronal view for
~a! fluence convolution (n53) –static dose, showing the 120% and 215%
isodose lines; and ~b! fluence convolution (n51) –static dose, showing the
135% and 230% isodose lines. Nonhighlighted differences are within
62%.
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appropriately modified as there is a change r , resulting from
the translation
u5
x8
r9
, v5
y8
r9
,
and
w5
z8
r9
where r95A~x821y821z82!. ~8!
3. Dose convolution
The influence of respiratory motion on the dose distribu-
tion was also evaluated using a dose convolution method,1
performed by convolving the static dose distribution, Dstatic ,
~calculated using Fstatic) with the function, Fmotion , de-
scribed above. The dose at a point r , that undergoes the
motion, is calculated as follows:
Dmotion~r !5Fmotion^ Dstatic
5E
r8
Fmotion~r2r8!Dstatic~r8!dr8. ~9!
This implementation has been modified from the original
version of Lujan et al.1 who only considered motion in the
FIG. 3. Dose volume histograms ~patient A! for ~a! the PTV and ~b! the
CTV, for the static and fluence convolved treatment plans. The dose axis is
scaled to emphasize the high gradient region of the DVH. Fluence con-
volved curves are included for breathing functions with varying degrees of
asymmetry (n51 – 3).Medical Physics, Vol. 31, No. 4, April 2004z-axis. Fmotion here is cast in the form of a 3-D discrete
matrix and the convolution with Dstatic is conducted along the
vector Rcom(x ,y ,z). As in the case with fluence convolution,
the amplitude uRcomu is divided into 3 mm equally spaced
bins with the exception of the last bin which is of variable
width.
C. Monte Carlo treatment planning
Treatment planning for three patients with tumors at dif-
ferent locations in the lung was conducted using the DPM
Monte Carlo code within the framework of the UMPlan sys-
tem. For all patients, static and fluence convolved planning
was performed independently using the breath-hold exhale
CT data sets. Dose convolved plans were generated by ap-
plying a post-processing convolution to the static beam dose
distribution. The typical treatment plan beam configuration
consisted of conformal 6/15 MV anterior, lateral and oblique
fields, combined with segmental fields ~directed from the
same angles! to produce a dose distribution of 10065%
within the PTV. All plans were normalized to 100% at the
isocenter.
DPM calculations were performed using a voxel size of
33333 mm3, a 2 mm step size, and low energy electron
and photon cut-off values of 200 and 50 keV, respectively.
For each treatment plan, approximately 1 billion histories per
field were simulated, resulting in 1s statistics of roughly less
than 1.5% in the calculated dose, if we include the 1% latent
uncertainty in the reconstructed fluence ~from the virtual
source!. The time required for these simulations was ap-
proximately 8 hours per 1 billion particles, running on a
single 1 GHz, VMS-based, Alpha processor.
III. RESULTS AND DISCUSSION
A. Influence of the breathing function asymmetry
Figure 1 shows plots of the probability as a function of
GTV-COM position (r), as described by Eq. ~5!, for differ-
ent values of n (n51,2,3). The probability of finding the
GTV-COM at exhale increases as the value of n increases
indicating that the breathing PDF becomes asymmetrically
weighted toward the exhale position with increasing n .18
Figure 2 shows difference maps between the fluence con-
volved and static dose distributions ~i.e., fluence–static! in
the coronal view for patient A. The fluence convolved calcu-
lations were performed by sampling breathing PDF’s @Eq.
~5!# for two different values of n (n51,3). An increase in
the dose differences ~fluence–static! is noted as the value of
n decreases; the maximum differences are approximately
620% for n53,630% for n52 and 640% for n51. This
trend is expected if we consider that the static treatment
plans were performed using the exhale CT scan—as n de-
creases the breathing function becomes more symmetric with
the result that a greater fraction of time is spent at the inhale
position relative to larger values of n . Figure 3 illustrates the
dose–volume-histogram ~DVH! for the static and fluence
convolved plans ~with n51 – 3), shown specifically for the
PTV @Fig. 3~a!# and the CTV @Fig. 3~b!#. We see that the
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decreases—the DVH shoulder is degraded while the high
dose region is increased showing the influence of the cold
and hot spots which worsen as n decreases. A similar trend
was found for the CTV DVH’s @Fig. 3~b!#, however, the
differences were less significant in comparison to the PTV as
a consequence of proper PTV design in the static plan.
B. Treatment planning analysis static vs motion
convolved planning
Amplitudes for the exhale/inhale excursion of the GTV-
COM are presented in Table I for the 3 patients planned in
this study. For patient A, the GTV-COM is found to move
1.3 cm in the superior direction and 0.6 cm anteriorly. The
largest motion for patient B was observed in the inferior
direction (;1 cm) and for patient C this occurred in the
anterior direction (;1 cm).
Illustrated in Fig. 4 are the dose difference maps in the
coronal view ~for patient A! for ~a! dose convolution (n
53)—static, and ~b! fluence (n53)—dose (n53). Note
that the difference map for the fluence convolution (n53)
and static dose distributions is presented in Fig. 2~a!. In the
difference maps shown in Figs. 2~a! and 4~a!, hot and cold
spots are located superiorly and inferiorly, respectively. This
is because the static treatment plans were conducted in the
exhale position and that the GTV-COM for this patient
moved predominantly in the superior direction during inhale;
that is, relative to the exhale position, the superior region of
the target moves out of the beam during inhale while the
inferior edge moves into the beam resulting in the respective
cold and hot spots. From the difference maps in Figs. 2~a!
and 4~a! we also see that the fluence and dose convolved
distributions are generally in good qualitative agreement,
however, a more detailed evaluation reveals some differ-
ences. In the fluence convolved case @Fig. 2~a!# the maxi-
mum and minimum differences are 125% and 220%,
respectively—these differences are not symmetric as there is
preferentially more dose deposited in the lung due to the
increased lateral electron transport in this region. This illus-
trates that fluence convolution is able to account for the
variation in tissue densities surrounding the target. For the
dose convolution situation @Fig. 4~a!# the maximum and
minimum differences are symmetric (625%) as the convo-
lution is spatially invariant, showing that this method does
TABLE I. Amplitudes of the GTV center-of-mass excursion between the
breath-hold exhale and inhale CT phases. Values along the independent axes
represent the absolute differences between the exhale and inhale positions.
The direction of motion along each of the patient axes is provided in paren-
theses. Also shown are the magnitudes of the Rcom (x ,y ,z) vector. Positive
movements from exhale to inhale are directed along the patient’s: left
(1x), posterior (1y), and superior (1z).
Patient A Patient B Patient C
x cm 0.17 ~lt.! 0.11 ~lt.! 0.21 ~rt.!
y cm 0.64 ~ant.! 0.24 ~ant.! 1.28 ~ant.!
z cm 1.26 ~sup.! 0.96 ~inf.! 0.09 ~sup.!
Rcom cm 1.42 1.00 1.30Medical Physics, Vol. 31, No. 4, April 2004not account for the influence of inhomogeneous tissues on
the dose distribution. The differences between fluence and
dose convolution are further demonstrated in Fig. 4~b!
~fluence–dose convolution! where we find positive differ-
ences up to 7%. Figure 5 illustrates the DVH’s for patient A
for ~a! the PTV ~differential! and ~b! the CTV ~integral!.
Plots are shown for the static and the fluence and dose con-
volved dose distributions. It is clear that there is a systematic
shift toward higher doses for the fluence convolved differen-
tial DVH @Fig. 5~a!# relative to the static and dose convolved
cases. The reason for this is that, while hot and cold spots are
found at the inferior and superior edges of the PTV, respec-
tively, the hot spots are greater and tend to dominate the
overall dose to the PTV. For the dose convolution plan the
PTV DVH more closely agrees with that of the static case
because the hot and cold spots tend to offset each other. CTV
differences between the static, fluence and dose convolved
plans are similar in trend to that of the PTV but are smaller
in magnitude as observed in Fig. 5~b!.
Dose difference maps and DVH’s for the motion con-
volved and static beam calculations for patient B are illus-
trated in Fig. 6. The beam arrangement for patient B was
similar to that of patient A, however, patient B differed with
respect to ~a! the location of the hot and cold spots, and ~b!
the location of the tumor. Figure 6~a! illustrates a difference
FIG. 4. Percentage dose difference maps ~patient A! in the coronal view for
~a! dose convolution (n53) –static dose, showing the 620% isodose lines;
and ~b! fluence convolution (n53) –dose convolution (n53), highlighting
the 12 to 16% dose difference region. Nonhighlighted differences are
within 62%.
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in the sagittal view, where the maximum and minimum dose
differences are 128% and 224%, respectively. These dif-
ferences are larger than those for patient A because the GTV
for patient B is surrounded by much more lung tissue. In
contrast to patient A, the hot and cold spots in the difference
maps for patient B are located superiorly and inferiorly re-
spectively; in the case of patient B, the GTV-COM moves
inferiorly during inhale resulting in a cold spot as the inferior
edge moves out of the beam, and a hot spot as the superior
edge moves into the beam. An analysis of the dose difference
map between the fluence and dose convolved distributions
showed maximum differences of 15%. Much like the case
of patient A, these differences were predominantly positive
and resulted from the shift invariance assumption of dose
convolution in the presence of inhomogeneous tissues.
DVH’s for the PTV for patient B are shown in Fig. 6~b!. A
subtle dose reduction at the shoulder of the PTV DVH is
noted for the motion ~fluence and dose! convolved plans,
however, the differences relative to the static case are fairly
insignificant. A likely reason for this is that the Monte Carlo
static dose calculation is expected to correctly account for
FIG. 5. Dose volume histograms ~patient A! for the static, fluence and dose
convolved treatment plans for ~a! the PTV ~differential DVH! and ~b! the
CTV. Fluence and dose convolved calculations were performed assuming a
breathing function with an n53 degree of asymmetry. The inset in ~b! high-
lights the high gradient region of the DVH.Medical Physics, Vol. 31, No. 4, April 2004the spread of dose from the target into the surrounding lung;
convolving the static dose in this region either by fluence or
dose convolution is therefore unlikely to cause a substantial
variance in the dose distribution relative to the static case.
This effect has been described previously.11 Similarly, differ-
ences in the CTV DVH’s between static and motion con-
volved plans were minimal suggesting that the PTV was
relatively well designed, i.e., the dose to the CTV was not
compromised in the presence of motion.
Presented in Fig. 7~a! is the fluence–static dose difference
display for the 7-field conformal beam arrangement for pa-
tient C. In this case, the largest differences (114% and
211%) occur in the AP direction—this is expected because
the GTV-COM moves predominantly in the anterior direc-
tion ~see Table I!. The difference map between the fluence
and dose convolved plans is shown in Fig. 7~b!. We see
differences of 14% in the vicinity of the PTV, however,
much larger differences are noted at the patient surfaces,
250% and 120% at the anterior and posterior surfaces,
respectively. As the patient moves posteriorly, the hot spot is
found at the anterior surface. This surface dose effect has
been previously described by Craig et al.,8 and occurs be-
FIG. 6. Percentage dose difference map ~patient B! in the sagittal view for
fluence convolution (n53) –static dose, showing the 610% isodose lines.
~b! shows dose volume histograms for the PTV. Included are plots for the
static, fluence and dose convolved treatment plans. The inset highlights the
high gradient region of the DVH.
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the dose distribution. Outside the patient, the dose is zero
with the result that there is no dose to ‘‘shift’’ into the
patient.8 Note that the surface dose limitation of dose convo-
lution was observed for the other patients in this study as
well. Unlike in the work by Craig et al.,8 we have not modi-
fied the dose convolution method to correct for the surface
dose irregularities. DVH’s for the CTV and PTV for patient
C were found to follow a different pattern compared to the
other two patients: fluence convolution predicts more dose to
both the CTV and PTV. One of the reasons for this is that the
tumor motion occurs mostly in the anterior–posterior direc-
tion, which coincides with the direction of some of the
beams used for the treatment plan. The decreased SSD in the
fluence motion compensated plan leads to an increased dose
to the PTV. This effect is not properly accounted for in the
dose convolved plan where the dose is precalculated at the
static SSD.
FIG. 7. Percentage dose difference maps ~patient C! in the sagittal view for
~a! fluence convolution (n53) –static dose showing the 65% isodose lines;
and ~b! fluence convolution (n53) –dose convolution (n53) showing the
15% and 225% isodose lines.Medical Physics, Vol. 31, No. 4, April 2004C. Beam edge vs inhomogeneity effects
In addition to hot/cold spots in the vicinity of the PTV, the
dose difference maps in the previous analyses ~Figs. 2, 4,
6–7! show differences along the beam edges. These differ-
ences are a result of the convolution of the static dose distri-
bution which tends to blur out the beam penumbra causing
an unsharp edge. In the case of fluence convolution, the dose
distribution is also influenced by the local tissue densities—
the dose distribution will be spatially variant in the presence
of inhomogeneous tissues. To better understand the beam
edge versus inhomogeneity effect on the motion convolved
dose distributions we performed a calculation for patient B
assuming that the CT densities were water equivalent ~all
values were set to 1.0!. The idea was to isolate the beam
edge differences from those due to the tissue inhomogene-
ities. Results of this analysis showed differences of up to
123% due only to the beam edge effect of the fluence con-
volution. The combined dose difference map ~fluence
convolution–static! in the heterogeneous density case
@shown earlier in Fig. 6~a!# includes both the beam edge and
inhomogeneity effects and shows maximum differences of
128%. The spatial variation of the dose distribution due to
the inhomogeneity effect, for this particular plan, was on the
order of 5%, which is consistent with the differences noted
between fluence and dose convolution for this same case.
IV. CONCLUSION
In this study we account for some of the effects of
breathing-induced target motion in the vicinity of the lung
using convolution methods. Significant hot and cold spots
(615% – 25%) were found in the dose difference maps be-
tween the motion convolved and static dose distributions as a
result of the target motion. Smaller differences were ob-
served between fluence and dose convolution—these differ-
ences are mainly due to the spatial invariance of the dose
convolution distribution in the presence of the low density
lung tissue. This investigation would not be complete with-
out addressing the limitations of convolution methods in ac-
counting for respiratory induced motion. Both fluence and
dose convolution methods do not address the dose per frac-
tion effects, which may potentially be important as recently
demonstrated in a study by Craig et al.9 In addition, dose
convolution assumes shift invariance of the dose distribution,
which is shown both here and in a recent study by Craig
et al.8 to have limitations. Finally, we have not included in
this study an evaluation of the doses to the normal lung
because convolution methods do not take into account the
increase in volume of the lung with inhalation. The change in
volume as well as the deformation of the normal lung tissue
during respiration2 must be correctly accounted for in order
to accurately estimate the dose to the lung. Some work19,20
has begun in this area but further investigation is clearly
warranted.
932 Chetty et al.: Lung GTV motion Monte Carlo calculations 932ACKNOWLEDGMENTS
This work has been supported in part by NIH Grant P01-
CA59827 and by a University of Michigan Cancer Center
grant funded by the John and Suzanne Munn Endowment.
a!Electronic mail: indrin@med.umich.edu
1 A. E. Lujan et al., ‘‘A method for incorporating organ motion due to
breathing into 3D dose calculations,’’ Med. Phys. 26, 715–720 ~1999!.
2 Y. Seppenwoolde et al., ‘‘Precise and real-time measurement of 3D tu-
mor motion in lung due to breathing and heartbeat, measured during
radiotherapy,’’ Int. J. Radiat. Oncol., Biol., Phys. 53, 822–834 ~2002!.
3 M. Engelsman et al., ‘‘The theoretical benefit of beam fringe compensa-
tion and field size reduction for iso-normal tissue complication probabil-
ity dose escalation in radiotherapy of lung cancer,’’ Med. Phys. 30,
1086–1095 ~2003!.
4 M. Rosu et al., ‘‘Alterations in normal liver doses due to patient motion,’’
Int. J. Radiat. Oncol., Biol., Phys. 57, 1472–1479 ~2003!.
5 A. E. Lujan et al., ‘‘A method for incorporating organ motion due to
breathing into 3D dose calculations,’’ Med. Phys. 26, 715–720 ~1999!.
6 G. S. Mageras et al., ‘‘A method of incorporating organ motion uncer-
tainties into three dimensional conformal treatment plans,’’ Int. J. Biol.
Phys. 35, 335–342 ~1996!.
7 S. D. McCarter et al., ‘‘Evaluation of the validity of a convolution
method for incorporating tumour movement and set-up variations into the
radiotherapy treatment planning system,’’ Phys. Med. Biol. 45, 923–931
~2000!.
8 T. Craig et al., ‘‘Limitations of a convolution method for modeling geo-
metric uncertainties in radiation therapy. I. The effect of shift invariance,’’
Med. Phys. 30, 2001–2011 ~2003!.
9 T. Craig et al., ‘‘Limitations of a convolution method for modeling geo-Medical Physics, Vol. 31, No. 4, April 2004metric uncertainties in radiation therapy. II. The effect of a finite number
of fractions,’’ Med. Phys. 30, 2012–2020 ~2003!.
10 W. A. Beckham et al., ‘‘A fluence-convolution method to calculate radia-
tion therapy dose distributions that incorporate random set-up error,’’
Phys. Med. Biol. 47, 715–720 ~1999!.
11 I. J. Chetty et al., ‘‘A fluence convolution method to account for respira-
tory motion in three-dimensional dose calculations of the liver: A Monte
Carlo study,’’ Med. Phys. 30, 1776–1780 ~2003!.
12 ICRU Report 50, International Commission on Radiation Units and Mea-
surements: Prescribing, recording and reporting photon beam therapy,
Bethesda, Maryland, 1993.
13 I. J. Chetty et al., ‘‘A virtual source model for Monte Carlo modeling of
arbitrary intensity distributions,’’ Med. Phys. 27, 166–172 ~2000!.
14 I. J. Chetty et al., ‘‘Photon beam relative dose validation of the DPM
Monte Carlo code in lung-equivalent media,’’ Med. Phys. 30, 563–573
~2003!.
15 J. Sempau et al., ‘‘DPM, a fast, accurate Monte Carlo code optimized for
photon and electron radiotherapy treatment planning calculations,’’ Phys.
Med. Biol. 45, 2263–2291 ~2000!.
16 J. M. Balter et al., ‘‘Improvement of CT-based treatment planning mod-
els of abdominal targets using static exhale imaging,’’ Inst. Phys. Conf.
Ser. 41, 939–943 ~1998!.
17 S. Shimizu et al., ‘‘Detection of lung tumor movement in real-time
tumor-tracking radiotherapy,’’ Int. J. Radiat. Oncol., Biol., Phys. 51,
304–310 ~2001!.
18 A. E. Lujan et al., ‘‘A method for incorporating organ motion due to
breathing into 3D dose calculations in the liver: Sensitivity to variations
in motion,’’ Med. Phys. 30, 2643–2649 ~2003!.
19 M. Ding et al., ‘‘Dose correlation for thoracic motion in radiation therapy
of breast cancer,’’ Med. Phys. 30, 2520–2529 ~2003!.
20 B. Schaly et al., ‘‘Accounting for variable anatomy in radiation therapy
dose distributions,’’ Med. Phys. 30, 1428 ~2003! ~abstract!.
